Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.

Su Jeong SongJi MinSung Yun SuhSun Hoi JungHyeon Joo HahnSeock-Ah ImJu-Yeun Lee

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2017)

One-fifth of breast cancer patients who were treated with taxane-based chemotherapy experienced TIPN receiving treatment, and its risk factors were paclitaxel use, old age, overweight, and metastatic cancer.

Keyphrases

risk factors
small cell lung cancer
physical activity
papillary thyroid
radiation therapy
combination therapy
weight gain
squamous cell
replacement therapy
smoking cessation
rectal cancer